RL
68
3
BA
49
-3
GWW
71
4
WAT
53
6
EFX
36
4
KO
44
2
MDLZ
36
2
MMC
60
6
TRV
56
3
MCO
75
2
NTAP
66
2
GS
73
7
PM
64
2
SBUX
39
3
ILMN
37
5
AMGN
38
-6
AVY
50
2
HBI
55
-4
LMT
32
-12
NRG
52
3
RL
68
3
BA
49
-3
GWW
71
4
WAT
53
6
EFX
36
4
KO
44
2
MDLZ
36
2
MMC
60
6
TRV
56
3
MCO
75
2
NTAP
66
2
GS
73
7
PM
64
2
SBUX
39
3
ILMN
37
5
AMGN
38
-6
AVY
50
2
HBI
55
-4
LMT
32
-12
NRG
52
3
Financhill
Back

Karyopharm Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
28

KPTI
Karyopharm Therapeutics

Last Price:
0.85
Seasonality Move:
-2.8%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
28
Karyopharm Therapeutics (KPTI) is a Sell

Is Karyopharm Therapeutics a Buy, Sell or Hold?

  • The current Karyopharm Therapeutics [KPTI] share price is $0.78. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • KPTI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KPTI Stock Price Chart

What is Karyopharm Therapeutics's stock price today?

  • The Karyopharm Therapeutics share price today is $0.78
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KPTI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 41.33 Sell
Chaikin Money Flow: -20521 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.81 - 0.91) Sell
Bollinger Bands (100): (0.76 - 0.92) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

KPTI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.82 Sell
20-day SMA: 0.86 Sell
50-day SMA: 0.82 Sell
200-day SMA: 1.02 Sell
8-day EMA: 0.81 Sell
20-day EMA: 0.84 Sell
50-day EMA: 0.84 Sell
200-day EMA: 1.01 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Karyopharm Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):